Golden Syrian hamsters are small rodents, but they display many features that resemble the physiology and metabolism of humans. [7], all of which are not observed in other rodents such as mice and rats. Consequently, hamsters, like humans, exhibit enhanced susceptibility to atherosclerosis (AS) and diabetes [8], which led to the widespread use of hamsters in studies on AS and diabetes.In the past 2-3 decades, due to the fast development of transgenic and knockout mice, hamsters were gradually replaced by these mouse models. However, due to multiple differences between mice and humans with respect to physiology and metabolism, the use of genemanipulated mice has limited value in disease modeling and pathophysiological studies. Extensive literature search has revealed an absence of reports on genetically manipulated hamster models. To capitalize on the special metabolic features of hamsters, we aim to generate genemanipulated hamsters as an alternate rodent model for general applications. As the initial step to create a genetically manipulated hamster, we utilized a highly efficient lentiviral vector to generate transgenic hamsters expressing enhanced green fluorescent protein (eGFP).By modifying and optimizing the protocols for producing transgenic mice and rabbits in our laboratory [9, 10], we developed a specific procedure for hamster superovulation, fertilized egg harvesting, perivitelline space microinjection and embryo transfer. After the successful culture of fertilized hamster eggs that developed into 4-and 8-cell embryos in vitro ( Figure 1A), we implanted these embryos into pseudopregnant females. We obtained 7-10 pups/litter in 4 out of 7 surrogate mothers. Next, we microinjected 50-100 picoliters of a lentiviral